SV Health Investors discuss the firm’s new $90M early-stage Medtech Convergence Fund

in SV News

Author: Lisa Carmel

Publication: Ximedica

Forging where others are tentative to trod, SV Health Investors, in partnership with Aaron Sandoski from Norwich Ventures, and Tejin launched a $90M Medtech Convergence Fund, focused on early stage investments in April 2020. Curious about the intent and vision, I connected with Paul LaViolette, Managing Partner and COO to learn more. Disclosure: SV Health Investors is majority share owner of Ximedica.

View the article